Recombinant Arabidopsis thaliana Acyl-CoA-binding domain-containing protein 1 (ACBP1) is a protein derived from the model plant Arabidopsis thaliana. It belongs to a family of acyl-CoA-binding proteins (ACBPs) that play crucial roles in lipid metabolism and stress responses in plants. ACBP1 is particularly notable for its membrane-associated localization, which includes the plasma membrane and endoplasmic reticulum, and its ability to bind acyl-CoA esters and phosphatidic acid (PA) .
ACBP1 contains an amino-terminal transmembrane domain that targets it to the plasma membrane and the endoplasmic reticulum. This localization is critical for its function in lipid metabolism and stress responses. Additionally, ACBP1 possesses C-terminal ankyrin repeats, which may facilitate interactions with other proteins .
ACBP1 is involved in several key biological processes:
Lipid Metabolism: ACBP1 can bind to acyl-CoA esters and phosphatidic acid, influencing the composition of membrane lipids. It regulates the expression of phospholipase Dα1 (PLDα1) and phospholipase Dδ (PLDδ), enzymes involved in the hydrolysis of phosphatidylcholine (PC) to PA .
Stress Responses: ACBP1 plays a role in freezing tolerance. Mutant plants lacking ACBP1 show enhanced freezing tolerance due to reduced PA levels and increased PC levels, which contribute to membrane stability. Conversely, overexpression of ACBP1 leads to increased sensitivity to freezing .
Cuticle Formation: ACBP1 is also involved in stem cuticle formation by trafficking very-long-chain acyl-CoA esters, which are precursors for wax biosynthesis. Mutants lacking ACBP1 exhibit reduced cuticular wax and altered cutin composition .
| Genotype | PA Levels | PC Levels | Freezing Tolerance | PLDα1 Expression | PLDδ Expression |
|---|---|---|---|---|---|
| ACBP1 Overexpressors | Increased | Decreased | Reduced | Up-regulated | Down-regulated |
| acbp1 Mutants | Decreased | Increased | Enhanced | Down-regulated | Up-regulated |
| Genotype | Cuticular Wax Composition | Cutin Monomers | Susceptibility to Pathogens |
|---|---|---|---|
| Wild Type | Normal | Normal | Normal |
| acbp1 Mutants | Reduced | Altered | Increased |
Recombinant AtACBP1 (10.4 kDa) contains a conserved acyl-CoA-binding (ACB) domain critical for interacting with long-chain (LC) and very-long-chain (VLC) acyl-CoA esters. Isothermal titration calorimetry (ITC) studies confirm its binding affinity for 18:1-, 18:2-, 18:3-, 24:0-, 25:0-, and 26:0-CoAs . The protein’s membrane-anchoring domain enables localization to cellular membranes, facilitating lipid transfer processes .
| Acyl-CoA Type | Binding Affinity (Kd) | Functional Implication | Source |
|---|---|---|---|
| 18:1-CoA | High | Phospholipid remodelling | |
| 24:0-CoA | High | Cuticular wax biosynthesis | |
| 18:0-CoA | Moderate | Galactolipid synthesis |
ACBP1 is differentially expressed across tissues:
High levels (143 μg/g FW) in developing Brassica napus seeds during triacylglycerol accumulation .
Stem-specific GUS expression in Arabidopsis transgenic lines, correlating with cuticle development .
ABA-induced expression in seedlings, linking ACBP1 to stress responses .
Western blotting and qRT-PCR are standard methods for quantifying expression levels .
Resolution: ACBP1 dual roles—binding acyl-CoAs for wax/cutin biosynthesis vs. interacting with PLDα1 to regulate PA production —suggest context-dependent functions. Mutant phenotypes highlight lipid class-specific dependencies.
Bimolecular Fluorescence Complementation (BiFC):
Yeast Two-Hybrid Assays:
Test for protein-protein interactions using bait (ACBP1) and prey (PLDα1) constructs.
Lipid Profiling:
Embryo lethality: acbp1acbp2 double mutants cannot survive beyond early stages, limiting adult-stage analysis .
Compensation mechanisms: Single mutants (e.g., acbp1) show normal growth, complicating functional studies .
Conditional knockouts: Use tissue-specific promoters to bypass embryonic lethality.
Lipidomics: Compare acyl-CoA and phospholipid profiles in wild-type vs. mutant embryos using LC-MS .
| Method | Application | Advantage | Limitation |
|---|---|---|---|
| GUS reporter assays | Track expression in transgenic lines | High spatial resolution | Limited to promoter activity |
| Immunoelectron microscopy | Visualize membrane association | Ultrastructural detail | Requires specialized equipment |
| Subcellular fractionation | Isolate membrane vs. cytosolic fractions | Quantitative analysis | Risk of cross-contamination |
Best Practice: Combine GUS assays with immunogold labeling to confirm tissue-specific and subcellular localization .
Hypothesis: ACBP1 amplifies PLDα1-mediated PA production, which is critical for ABA signaling but not directly linked to osmotic stress responses .
Phenotype comparison: Assess ABA germination inhibition vs. drought survival in ACBP1-OE lines.
Gene expression profiling: Monitor RD29A, AREB1, and MYC2 (ABA-responsive) vs. P5CS1 (proline synthesis) under stress .
Evidence: acbp1 mutant leaves show increased susceptibility to Botrytis cinerea, suggesting ACBP1 modulates cuticle integrity or defense-related lipid signaling .
Lipid profiling: Compare VLC fatty acid profiles in infected vs. non-infected tissues.
Gene co-expression networks: Identify ACBP1’s regulatory targets in pathogen response pathways.
Case Study: acbp1 mutants show reduced VLC acyl-CoA binding but unchanged expression of wax biosynthetic genes like CER1 or CER3.
Metabolite flux analysis: Track acyl-CoA ester turnover rates using isotopic labeling.
ChIP-seq: Determine if ACBP1 regulates transcription factors (e.g., WIN1/SHN1) that control wax-related genes.
Negative control: Recombinant ACBP1 incubated with palmitoyl-CoA (C16:0-CoA) to confirm chain-length specificity .
Competition assay: Add excess unlabeled acyl-CoA esters to confirm binding specificity.
Data Validation: Use ITC to measure binding thermodynamics (ΔH, ΔS) and confirm stoichiometry .